TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ADAG

Adagene Inc

Healthcare · Biotechnology

2.90$ -1.7% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Adagene Inc (ADAG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 62.7% of the shares are freely tradable; institutional investors hold 12.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 12.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 21.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 62.7%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 67Mio.

Largest Shareholders

Institutions

Institutions ADAG
Name Stake (%) Shares Change (%) Date
HSG Holding Ltd 2.00 1,343,364 +0.0 03/31/2026
Squadron Capital Management LLC 1.86 1,250,000 +0.0 06/30/2026
Ameriprise Financial Inc 0.91 607,903 +0.0 03/31/2026
Citadel Advisors Llc 0.76 506,934 +0.0 06/30/2026
Exome Asset Management LLC 0.73 488,293 -33.7 06/30/2026
Mill Creek Capital Advisors LLC 0.30 199,610 +0.0 03/31/2026
Quadrature Capital Limited 0.12 80,487 +592.8 06/30/2026
Morgan Stanley - Brokerage Accounts 0.10 66,148 -12.6 03/31/2026
Amvescap Plc. 0.07 47,124 +0.0 03/31/2026

Funds

Funds ADAG
Name Stake (%) Shares Change (%) Date
Fullgoal Glb Healt Life Alloc(QDII)USD 0.22 150,001 +42.9 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings ADAG
Person Role Shares Value As of Type
Luo Peter Chief Executive Officer 88,535 256,752 $ Sep 16, 2026 direct
Tam Man Kin Chief Financial Officer 12,000 34,800 $ Sep 23, 2026 direct
Do Cuong V Director 2,000 5,800 $ Aug 14, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 23, 2026 Tam Man Kin Chief Financial Officer Buy 2,000 3.00 6,000
Sep 16, 2026 Luo Peter Chief Executive Officer Buy 20,290 3.15 63,980
Aug 14, 2026 Do Cuong V Director Buy 2,000 3.75 7,500

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?